ALAN BASH - 01 Mar 2022 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Kleem Chaudhary, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
02 Mar 2022, 15:10:21 UTC
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +575,000 $0.000000 575,000 01 Mar 2022 Common Stock 575,000 $2.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest 25% on the first anniversary of the grant date and in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continued service through such date.